Historical shareholding details of UBS Asset Mgmt Americas Inc holdings in Halozyme Therapeutics Inc. (HALO)

Monthly changes of UBS Asset Mgmt Americas Inc shareholding in Halozyme Therapeutics Inc. over the previous months

Month Name Total no. shares held Percent Holding
Dec 31, 2024 Ubs Asset Mgmt Americas Inc 389,875 0.32%
Sep 30, 2024 Ubs Asset Mgmt Americas Inc 397,833 0.31%
Jun 30, 2024 Ubs Asset Mgmt Americas Inc 432,024 0.34%
Mar 31, 2024 Ubs Asset Mgmt Americas Inc 160,954 0.13%
Dec 31, 2023 Ubs Asset Mgmt Americas Inc 161,180 0.13%
Sep 30, 2023 Ubs Asset Mgmt Americas Inc 157,537 0.12%
Jun 30, 2023 Ubs Asset Mgmt Americas Inc 334,608 0.25%
Mar 31, 2023 Ubs Asset Mgmt Americas Inc 334,608 0.25%
Dec 31, 2022 Ubs Asset Mgmt Americas Inc 518,479 0.39%

View all ownership details of Halozyme Therapeutics Inc.